Sauer L A, Chapman J C, Dauchy R T
Institute for Medical Research, Mary Imogene Bassett Hospital, Cooperstown, New York 13326.
Endocrinology. 1994 Feb;134(2):751-9. doi: 10.1210/endo.134.2.8299570.
3 beta-Hydroxy-5-ene-steroid dehydrogenase/delta 5-delta 4-isomerase (3 beta HSD) is a NAD(+)-dependent membrane-bound enzyme that catalyzes the oxidation of delta 5-3 beta-hydroxysteroids to delta 4-3-keto structures during adrenal, gonadal, and placental steroidogenesis. Enzyme activity is located in both microsomes and mitochondria. In these experiments we examined the membrane topologies of 3 beta HSD in rat and calf adrenal microsomes and mitochondria by comparing access to the active sites of coenzyme and the inhibitor mersalyl, a nonpenetrant organic mercurial anion. Microsomal activity required exogenous NAD+ and was inhibited by mersalyl, indicating that the active site faced the medium in vitro and the cytoplasm in vivo. In contrast, mitochondrial 3 beta HSD used matrix space NAD+, was inhibited by reduction of intramitochondrial NAD(P)+, and was insensitive to mersalyl. Mitochondrial activity was decreased by exogenous NADH (apparent Ki, 2.8 microM) and increased by added NAD+ (apparent Ka, 2.4 microM). However, mersalyl blocked the effects of exogenous NADH and NAD+ and returned the activity to that observed before coenzyme addition. The membrane-sidedness of the NAD+ activation was examined further in submitochondrial particles prepared by sonication of pyridine nucleotide-depleted calf adrenal cortex mitochondria. Particles were prepared in the absence or presence of 10 mM NAD+ and contained none or 2.9-7.3 nmol NAD+/mg protein, respectively. Both groups of submitochondrial particles required exogenous NAD+ for 3 beta HSD activity, indicating that the active site faced the medium (the particles were everted), and the contained NAD+ was inside the particles. However, 3 beta HSD activity was increased 12-140% in particles that contained NAD+. The results suggest that mitochondrial 3 beta HSD is an integral inner membrane protein, that the active site faces the matrix space and is influenced by coenzyme availability, and that a regulatory site(s) faces the intermembrane space. Binding of NAD+ or NADH to this external site increases or decreases, respectively, the rate of catalysis at the active site. Mitochondrial 3 beta HSD activity may be enhanced by oxidation of intermembrane space NADH via an active rotenone- and antimycin-a-insensitive NADH oxidase.
3β-羟基-5-烯类固醇脱氢酶/δ5-δ4-异构酶(3βHSD)是一种依赖烟酰胺腺嘌呤二核苷酸(NAD⁺)的膜结合酶,在肾上腺、性腺和胎盘类固醇生成过程中,催化δ5-3β-羟基类固醇氧化为δ4-3-酮结构。酶活性存在于微粒体和线粒体中。在这些实验中,我们通过比较辅酶和抑制剂汞撒利(一种非渗透性有机汞阴离子)对活性位点的可及性,研究了大鼠和小牛肾上腺微粒体及线粒体中3βHSD的膜拓扑结构。微粒体活性需要外源性NAD⁺,并被汞撒利抑制,这表明活性位点在体外面向介质,在体内面向细胞质。相反,线粒体3βHSD利用基质空间中的NAD⁺,被线粒体内NAD(P)⁺的还原所抑制,且对汞撒利不敏感。线粒体活性被外源性NADH降低(表观抑制常数Ki为2.8μM),被添加的NAD⁺增加(表观活化常数Ka为2.4μM)。然而,汞撒利阻断了外源性NADH和NAD⁺的作用,并使活性恢复到添加辅酶前的水平。通过对用吡啶核苷酸耗尽的小牛肾上腺皮质线粒体进行超声处理制备的亚线粒体颗粒,进一步研究了NAD⁺活化的膜侧性。颗粒在不存在或存在10 mM NAD⁺的情况下制备,分别不含或含有2.9 - 7.3 nmol NAD⁺/mg蛋白质。两组亚线粒体颗粒的3βHSD活性都需要外源性NAD⁺,这表明活性位点面向介质(颗粒是外翻的),且所含的NAD⁺在颗粒内部。然而,在含有NAD⁺的颗粒中,3βHSD活性增加了12% - 140%。结果表明,线粒体3βHSD是一种整合的内膜蛋白,活性位点面向基质空间,并受辅酶可用性的影响,且一个调节位点面向膜间隙。NAD⁺或NADH与这个外部位点的结合分别增加或降低活性位点的催化速率。线粒体3βHSD活性可能通过膜间隙NADH经一种对鱼藤酮和抗霉素A不敏感的NADH氧化酶氧化而增强。